PharmaCyte Biotech, Inc.
PMCB
$1.19
$0.043.48%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -72.63% | -71.62% | -56.29% | -26.25% | -15.73% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -30.36% | 52.60% | 170.80% | 141.23% | 64.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -72.42% | -71.07% | -56.02% | -25.98% | -15.54% |
|
|
|||||
| Total Current Assets | -72.42% | -71.07% | -56.02% | -25.98% | -15.54% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -56.35% | -56.35% | -56.35% | -56.35% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 41.36% | 95,493.51% | 86,259.74% | 102,688.31% | 61,324.68% |
| Total Assets | -38.58% | -30.15% | -12.13% | -18.25% | -8.46% |
|
|
|||||
| Total Accounts Payable | 0.14% | 176.23% | -22.85% | 203.51% | 8.59% |
| Total Accrued Expenses | -8.39% | -30.54% | 42.52% | 60.42% | 102.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 547.72% | 1,849.62% | -- | -- |
| Total Other Current Liabilities | -- | 547.72% | 1,849.62% | -- | -- |
| Total Current Liabilities | -46.91% | 177.88% | 392.29% | 170.70% | 171.77% |
|
|
|||||
| Total Current Liabilities | -46.91% | 177.88% | 392.29% | 170.70% | 171.77% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -84.03% | -55.88% | -48.73% | -- | -- |
| Total Liabilities | -79.17% | -32.64% | -15.90% | 2,381.40% | 1,974.98% |
|
|
|||||
| Common Stock & APIC | -4.12% | -6.32% | -9.65% | -8.35% | -6.43% |
| Retained Earnings | 17.31% | 19.49% | 22.82% | 0.29% | -0.98% |
| Treasury Stock & Other | -8.76% | -9.28% | -6.92% | -209.67% | -340.88% |
| Total Common Equity | 28.29% | 18.18% | 11.65% | -61.97% | -59.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -68.17% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -68.17% | -- | -- |
|
|
|||||
| Total Common Equity | 28.29% | 18.18% | 11.65% | -61.97% | -59.32% |
| Total Preferred Equity | -- | -- | -68.17% | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.71% | -29.45% | -10.83% | -37.61% | -29.74% |
|
|
|||||